BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4083636)

  • 1. [Results of bromocriptine treatment of giant or invasive prolactin adenomas. Apropos of 20 cases].
    Scherrer H; Turpin G; De Gennes JL; Schaison-Cusin M; Heshmati HM; Thibierge M; Metzger J
    Ann Med Interne (Paris); 1985; 136(6):459-66. PubMed ID: 4083636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
    Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
    Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
    Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome.
    Hubbard JL; Scheithauer BW; Abboud CF; Laws ER
    J Neurosurg; 1987 Dec; 67(6):816-21. PubMed ID: 3681421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid regression of pituitary prolactinomas during bromocriptine treatment.
    Thorner MO; Martin WH; Rogol AD; Morris JL; Perryman RL; Conway BP; Howards SS; Wolfman MG; MacLeod RM
    J Clin Endocrinol Metab; 1980 Sep; 51(3):438-45. PubMed ID: 6773972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of prolactinomas associated with very high serum prolactin levels.
    Barrow DL; Mizuno J; Tindall GT
    J Neurosurg; 1988 Apr; 68(4):554-8. PubMed ID: 3351583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of postoperative bromocriptine treatment for prolactin-secreting pituitary adenomas].
    Sato O; Niwa J; Inoue Y; Akagawa S; Kobayashi K
    No Shinkei Geka; 1983 Jan; 11(1):51-60. PubMed ID: 6682184
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tamoxifen administration on prolactin release by invasive prolactin-secreting pituitary adenomas.
    Lamberts SW; Verleun T; Oosterom R
    Neuroendocrinology; 1982; 34(5):339-42. PubMed ID: 7078703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bromocriptine treatment of prolactinomas and primary hyperprolactinemia (author's transl)].
    Fossati P; Grenier JL; Stevenard C; Fermon C; Christiaens JL; Linquette M
    Ann Med Interne (Paris); 1982; 133(1):45-7. PubMed ID: 7065588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter study.
    Brue T; Lancranjan I; Louvet JP; Dewailly D; Roger P; Jaquet P
    Fertil Steril; 1992 Jan; 57(1):74-80. PubMed ID: 1730334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy following transsphenoidal resection of prolactin-secreting pituitary tumors.
    Laws ER; Fode NC; Randall RV; Abboud CF; Coulam CB
    J Neurosurg; 1983 May; 58(5):685-8. PubMed ID: 6834116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin secreting adenoma in 22 men.
    Grisoli F; Vincentelli F; Jaquet P; Guibout M; Hassoun J; Farnarier P
    Surg Neurol; 1980 Apr; 13(4):241-7. PubMed ID: 7376059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathological changes of prolactinomas treated with bromocriptine].
    Teramoto A; Takakura K; Fukushima T; Osamura Y
    No Shinkei Geka; 1982 Jun; 10(6):619-27. PubMed ID: 7121729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactinomas and optic nerve compression: disappearance of suprasellar extension and visual recovery after two weeks bromocriptine treatment.
    Woodhouse NJ; Khouqueer F; Sieck JO
    Horm Res; 1981; 14(3):141-7. PubMed ID: 7286886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
    Esiri MM; Bevan JS; Burke CW; Adams CB
    J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
    Bonneville JF; Poulignot D; Cattin F; Couturier M; Mollet E; Dietemann JL
    Radiology; 1982 May; 143(2):451-5. PubMed ID: 7071347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine treatment of prolactinomas.
    Aronoff SL; Daughaday WH; Laws ER
    N Engl J Med; 1979 Jun; 300(24):1391. PubMed ID: 440366
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid resolution of visual field defects and reduction in macroprolactinoma size with bromocriptine therapy. A case report.
    Kahn SE; Miller JL
    S Afr Med J; 1982 Oct; 62(19):696-9. PubMed ID: 7135127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.